Diabetes, Obesity & Metabolism·Jul 10What is the 'real-world' experience with fixed-ratio combination therapy (insulin + GLP-1 receptor agonist) in routine clinical practice? Take-home messages for clinicians regarding key outcomesReviewInterventionsPaper
Diabetes, Obesity & Metabolism·Nov 28Treatment persistence, adherence and healthcare resource utilisation for iGlarLixi versus basal-bolus insulin or premixed insulin in older adult ethnic minorities with type 2 diabetes: SoliEthnicity studyCohort study in peopleType 2 diabetesPaper
Medicine·Sep 1Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitusCohort study of 192 peopleAcarbosePaper